{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Soligenix, Inc."},"Symbol":{"label":"Symbol","value":"SNGX"},"Address":{"label":"Address","value":"29 EMMONS DRIVE,SUITE B-10, PRINCETON, New Jersey, 08540, United States"},"Phone":{"label":"Phone","value":"+1 609 538-8200"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19)."},"CompanyUrl":{"label":"Company Url","value":"https://www.soligenix.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher J. Schaber","title":"Chairman, President & Chief Executive Officer"},{"name":"Oreola Donini","title":"Chief Scientific Officer & Senior Vice President"},{"name":"Richard C. Straube","title":"Chief Medical Officer & Senior Vice President"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}